Dr. Gene Schaefer is currently Senior Director, API Large Molecule Pharmaceutical Development & Manufacturing Sciences at Johnson & Johnson in Malvern, PA. In this role he is responsible for a number of projects from early stage process development to commercial product support for protein therapeutics.
Prior to joining Johnson & Johnson in 2008, Dr Schaefer was Director, Process Technologies, for seven years in the Protein Therapeutics Development group at Bristol-Myers Squibb Co. in Hopewell, New Jersey responsible for the process development and early clinical manufacturing of a number of protein therapeutics. Prior to joining Bristol-Myers Squibb, Dr. Schaefer had worked at Schering-Plough in Union, New Jersey for more than thirteen years. He was most recently Director, Biotechnology Development, supporting alpha interferon as well as other recombinant protein and viral products in development. Dr. Schaefer previously worked for Genzyme in Boston and the UK, developing processes for a number of protein and carbohydrate products.
He received a B.S. degree in Chemical Engineering from Princeton University in 1976 and his M.S. and Sc.D. degrees in Biochemical Engineering from M.I.T. in 1980 and 1985 respectively.